Subscribe For Free! Sign up to receive the print magazine six times per year and the e-mail newsletter twice a month. Learn more >
Packaged wet wipes give hospital personnel and patients a weapon to fight the spread of bacteria. Sustainable packaging of these wipes could be next. ...The healthcare community is understandably concerned with the spread of diseases such as MRSA (Methicillin-Resistant Staphylococcus Aureus), or staph, and C. Diff (Clostridium Difficile), a diarrheal disease. One way to combat such diseases, either in a medical facility or at home, is through hygiene, which may include the use of specialized wet wipes, contract-manufactured and packaged by Fredonia, WI-based Guy & O’Neill, Inc. for a wide range of customers and applications.
Certain types of cancer are becoming "chronic" diseases and call for changes in packaging, according to Dr. Joseph Gligorov, an oncologist in France. He made these remarks February 6, 2008, at Pharmapack in Paris, France, during a session titled, "Cancer Treatment: The Emerging Role of Packaging." While cancer rates are growing around the world, from 10 million cases diagnosed in 2000 to 15 million projected in 2020, many of these are due to the aging population, people who may also suffer from a variety of other ailments. More than 650 drugs to fight cancer are currently in the pipeline.
Pharmaceutical firms seek packaging line improvements to cut costs, biologics present packaging challenges, and medical device growth is driven by aging baby boomers. These treatment advances bode well for the healthcare/life sciences packaging community. Packaging materials need to offer protection from point of manufacture to the “last mile” where healthcare products reach a patient. Packaging materials must provide barriers for moisture, oxygen, light and heat, and they may include overt and/or covert security measures to combat counterfeiting and diversion. Equipment will need to package products more efficiently, be validatable and versatile.
Wyeth’s Charlie Portwood and Teva Global Generic Resource’s Uri Boneh will serve among the keynote speakers at The International Society for Pharmaceutical Engineering’s (ISPE) annual meeting Nov. 4 – 7 at Caesars Palace in Las Vegas. The event will feature more than 40 sessions, with topics including packaging, product quality lifecycle implementation, pandemic flu preparedness, personalized medicine, nanotechnology, disposables, and project management.
• Biopharmaceutical and biomedical technologies and treatments will be advanced in large part by developing countries. Although only 5% to 7% of biological products now in clinical development will actually make it to the market, they will play an important role as the life sciences industry begins to develop custom solutions for individual patients rather than focusing exclusively on the larger market. But such treatments will require a change in packaging and processing methods, as well as regulatory procedures.
Drug delivery devices, advances in combination products, and biologics/biopharmaceuticals will present both challenges and opportunities for packagers. New packages and drug delivery methods for over-the-counter (OTC) drugs, nutraceutical and cosmeceutical products are appearing on retail drug and grocery store shelves. (Part II of II)
Personalized medicine packs the potential to revolutionize drug packaging and distribution. Essentially, personalized medicine would allow a doctor to prescribe precisely the right drug at the right dose to an individual based on that person’s unique DNA.
This exciting possibility stems from the Human Genome Project (HGP), a 13-year research endeavor completed in 2003. Coordinated by the U.S. Department of Energy and the National Institutes of Health, HGP identified the genes that make up human DNA. That research helped create the field of genetics. Diseases have a genetic component, be it inherited or stemming from the body’s response to environmental stresses.
